<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB43 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RAB43</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB43</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RAB43" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RAB43 (RAB43, Member RAS Oncogene Family) is a member of the RAB GTPase family of small GTP-binding proteins that function as molecular switches in intracellular membrane trafficking. Located on chromosome 7q21.3, RAB43 plays specialized roles in vesicular transport pathways, particularly in the trafficking between the Golgi apparatus and endosomes, as well as in lysosomal delivery and phagocytic pathways. The gene has attracted significant attention in neurodegenerative disease research due to its involvement in Parkinson's disease pathogenesis and its role in lysosomal function, which is critically impaired in several neurodegenerative conditions[@bezzi2021].
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RAB43 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RAB43</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB43</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RAB43" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
RAB43 (RAB43, Member RAS Oncogene Family) is a member of the RAB GTPase family of small GTP-binding proteins that function as molecular switches in intracellular membrane trafficking. Located on chromosome 7q21.3, RAB43 plays specialized roles in vesicular transport pathways, particularly in the trafficking between the Golgi apparatus and endosomes, as well as in lysosomal delivery and phagocytic pathways. The gene has attracted significant attention in neurodegenerative disease research due to its involvement in Parkinson's disease pathogenesis and its role in lysosomal function, which is critically impaired in several neurodegenerative conditions[@bezzi2021].
The RAB family of proteins comprises over 60 members in humans, each typically regulating specific trafficking pathways between defined membrane compartments. RAB43 represents a relatively understudied member of this family with unique tissue distribution and functional specialization. Its expression is enriched in the brain, particularly in regions affected in Parkinson's disease, including the basal ganglia and cerebellum, making it a subject of interest for understanding neurodegeneration mechanisms.
The RAB43 gene (NCBI Gene ID: 201164, Ensembl: ENSG00000137601) is located on the long arm of chromosome 7 at position 21.3. The gene spans approximately 8.5 kilobases and consists of 6 exons encoding a protein of 215 amino acids. The genomic context includes several nearby genes involved in cell adhesion and signaling, though RAB43 appears to have distinct regulatory elements controlling its tissue-specific expression.
The promoter region of RAB43 contains elements that drive expression in neuronal and immune cell types. Transcription factors including Sp1, AP-1, and neuronal-specific regulators contribute to the brain-enriched expression pattern observed for this gene.
The RAB43 protein (UniProt: Q86YS7) is a small GTP-binding protein of approximately 24 kDa that belongs to the RAB family within the Ras superfamily of GTPases. Like other RAB proteins, RAB43 cycles between an active GTP-bound state and an inactive GDP-bound state, with this cycle regulated by:
GTPase-activating proteins (GAPs): Accelerate GTP hydrolysis, returning RAB43 to the inactive state Guanine nucleotide exchange factors (GEFs): Promote GDP release and GTP binding, activating RAB43 GDP dissociation inhibitors (GDIs): Extract GDP-bound RAB43 from membranes for recycling
The protein contains conserved motifs involved in GTP binding and hydrolysis:
RAB43 participates in several critical trafficking pathways:
Golgi-Endosomal Trafficking: RAB43 regulates transport between the Golgi apparatus and early endosomes. This pathway is essential for proper sorting of proteins destined for lysosomes, the plasma membrane, or recycling back to the Golgi. The protein functions at the interface between the biosynthetic and endocytic pathways, ensuring proper distribution of cargo proteins[@stafa2014].
Lysosomal Delivery: RAB43 contributes to trafficking of proteins to lysosomes, including hydrolytic enzymes and membrane proteins. This function is particularly important in neurons, where lysosomal function is essential for clearance of protein aggregates and damaged organelles.
Phagocytosis: In specialized cell types such as macrophages and microglia, RAB43 plays a role in phagocytic pathway. This function has relevance to neuroinflammation, where activated microglia perform phagocytic clearance of debris and protein aggregates.
In neuronal cells, RAB43 contributes to several critical functions:
Synaptic Vesicle Trafficking: RAB43 is involved in synaptic vesicle dynamics, participating in the regulated secretion of neurotransmitters. The protein may function in vesicle maturation or trafficking within the synaptic terminal.
Autophagy-Lysosome Pathway: RAB43 plays a role in the autophagy-lysosome pathway, which is essential for clearance of damaged proteins and organelles. This pathway is particularly important in post-mitotic neurons that cannot dilute damaged components through cell division[@hanson2015].
Mitochondrial Dynamics: Recent studies suggest RAB43 may influence mitochondrial distribution and function in neurons, potentially affecting neuronal energy metabolism and calcium handling[@hu2020].
Multiple lines of evidence implicate RAB43 in Parkinson's disease pathogenesis:
Genetic Associations: Genome-wide association studies have identified variants in the RAB43 genomic region that may influence PD risk. While not as strongly associated as established PD genes (LRRK2, GBA, SNCA), RAB43 variants may contribute to disease susceptibility in specific populations[@park2023].
Expression Changes: Transcriptomic analyses of PD patient brain tissue reveal altered RAB43 expression in the substantia nigra and other affected regions. These changes correlate with disease severity and may reflect compensatory responses or pathogenic mechanisms.
Functional Studies: In cellular and animal models of PD, RAB43 knockdown or overexpression affects viability of dopaminergic neurons. The protein appears to be protective in some contexts, while dysregulation contributes to toxicity.
RAB43 contributes to PD through several mechanisms:
Lysosomal Dysfunction: RAB43 is required for efficient lysosomal trafficking. In PD, where lysosomal function is impaired, RAB43 dysfunction may exacerbate accumulation of damaged proteins and organelles. The protein interacts with other PD-related proteins involved in lysosomal function, including ATP13A2 (PARK9)[@zavodszky2018].
Alpha-Synuclein Trafficking: RAB43 affects the intracellular trafficking of alpha-synuclein, the protein that forms Lewy bodies in PD. Altered RAB43 function may influence alpha-synuclein aggregation and clearance pathways[@yang2022].
Mitochondrial Dysfunction: Through effects on mitochondrial dynamics and quality control, RAB43 may influence the survival of dopaminergic neurons that are particularly vulnerable in PD.
Neuroinflammation: RAB43 is expressed in microglia, the immune cells of the brain. Changes in microglial RAB43 function may affect the neuroinflammatory environment in PD.
RAB43 interacts with several proteins implicated in familial Parkinson's disease:
LRRK2: RAB43 may function downstream of LRRK2, which phosphorylates several RAB proteins. The LRRK2-RAB43 pathway could be relevant for understanding LRRK2-associated PD.
GBA: The glucocerebrosidase gene, when mutated, causes Gaucher's disease and increases PD risk. RAB43 lysosomal trafficking may be affected by GBA deficiency.
VPS35: The retromer component VPS35, mutated in some PD cases, functions in endosomal trafficking. RAB43 may cooperate with retromer function.
RAB43's role in lysosomal trafficking makes it relevant to lysosomal storage disorders (LSDs), many of which have neurodegenerative manifestations:
Gaucher Disease: The most common LSD, caused by GBA mutations. RAB43 function may be affected by the accumulation of glucosylceramide, potentially contributing to neuronal dysfunction.
Niemann-Pick Disease: Type C disease involves defective cholesterol trafficking through late endosomes/lysosomes. RAB43-dependent pathways may be impaired.
Pantothenate Kinase Neurodegeneration (PKAN): RAB43 expression changes have been observed in models of this disease.
While primarily studied in PD, RAB43 may have relevance to Alzheimer's disease:
Endolysosomal Dysfunction: Early AD features include endolysosomal abnormalities. RAB43, as a regulator of this pathway, may contribute.
Amyloid Processing: Some evidence suggests RAB43 may affect amyloid precursor protein processing, though this requires further investigation.
RAB43 expression changes have been reported in ALS models and patient tissue. The protein's role in membrane trafficking and autophagy may be relevant to the pathogenesis of motor neuron disease.
RAB43 exhibits distinct expression patterns in the central nervous system:
At the cellular level, RAB43 is expressed in:
RAB43 expression is dynamically regulated during development:
RAB43 has potential as a biomarker for neurodegenerative disease:
Cerebrospinal Fluid: RAB43 protein levels can be measured in CSF. Changes may reflect neuronal dysfunction.
Blood: Peripheral blood cell RAB43 expression may provide information about disease state.
Imaging: PET ligands targeting RAB43-containing compartments are under development.
RAB43 and related pathways represent potential therapeutic targets:
RAB43 Modulators: Small molecules that enhance or inhibit RAB43 function could modify disease progression. However, specificity remains challenging.
Effector Targeting: Rather than targeting RAB43 directly, modulating its effectors may provide more selective effects.
Downstream Pathway Modulation: Targeting pathways downstream of RAB43 (autophagy, lysosomal function) may provide benefit.
Therapeutic targeting of RAB43 faces several challenges:
Specificity: The RAB family has many closely related members. Achieving selective targeting is difficult.
Cell-Type Specificity: Therapeutic approaches must target neurons specifically to avoid peripheral effects.
Compensatory Mechanisms: Cells may compensate for RAB43 modulation through other RAB proteins.
Key methods for studying RAB43 include:
Research utilizes multiple models:
The endolysosomal system is critical for neuronal homeostasis, and RAB43 dysfunction contributes to its impairment in neurodegenerative diseases:
Early Endosome Dysfunction: RAB43 participates in early endosome formation and sorting. In neurodegenerative conditions, early endosomes become enlarged and dysfunctional, with impaired cargo sorting. This leads to accumulation of undigested material and disruption of trafficking pathways.
Late Endosome and Lysosome Maturation: RAB43 is required for proper fusion of late endosomes with lysosomes. When this process is impaired, lysosomal function decreases, leading to accumulation of autophagic cargo and protein aggregates. The acidic environment necessary for lysosomal hydrolase activity is compromised.
Cargo Sorting Errors: Proper sorting of proteins to different cellular destinations is disrupted when RAB43 function is impaired. Proteins that should be degraded accumulate, while those needed for neuronal function may be mislocalized.
RAB43 plays a key role in autophagy, a critical process for neuronal survival:
Autophagosome Formation: RAB43 contributes to the early stages of autophagosome formation. The protein may help recruit membrane sources for the growing isolation membrane.
Autophagosome-Lysosome Fusion: Fusion of autophagosomes with lysosomes requires RAB43 function. This step is particularly important for neuronal quality control, as neurons rely on autophagy to clear damaged proteins and organelles.
Selective Autophagy: RAB43 may participate in selective autophagy pathways, including mitophagy (mitochondrial quality control) and aggrephagy (protein aggregate clearance). Defects in selective autophagy contribute to neurodegeneration.
RAB43 dysfunction promotes protein aggregation through multiple mechanisms:
Impaired Clearance: Lysosomal dysfunction resulting from RAB43 impairment reduces clearance of misfolded proteins. These proteins accumulate and aggregate, forming the inclusions characteristic of neurodegenerative diseases.
Altered Trafficking: RAB43-dependent trafficking pathways affect the subcellular distribution of aggregation-prone proteins. Mislocalization may promote aggregation by bringing proteins into proximity with membranes or other factors that catalyze aggregation.
Stress Response Dysfunction: Cells respond to protein aggregation with stress responses including the unfolded protein response (UPR) and heat shock response. RAB43 dysfunction impairs these adaptive responses.
RAB43 affects mitochondrial quality control in neurons:
Mitochondrial Dynamics: RAB43 influences mitochondrial fission and fusion dynamics. These processes are essential for maintaining a healthy mitochondrial population, and their disruption leads to mitochondrial dysfunction.
Mitophagy: RAB43 is involved in mitophagy, the selective degradation of damaged mitochondria. Impaired mitophagy allows dysfunctional mitochondria to accumulate, producing reactive oxygen species and ATP deficiency.
Mitochondrial Distribution: Proper distribution of mitochondria within neurons is essential for meeting energy demands at synapses. RAB43 dysfunction may impair mitochondrial trafficking.
RAB43 has potential as a diagnostic biomarker:
CSF RAB43: Levels of RAB43 protein in cerebrospinal fluid can be measured by ELISA. Changes in CSF RAB43 may reflect neuronal dysfunction or lysosomal pathology.
Blood Biomarkers: RAB43 expression in peripheral blood cells may provide information about disease state. Monocytes and lymphocytes show disease-related changes in RAB43.
Expression Signatures: Gene expression signatures including RAB43 may distinguish different neurodegenerative conditions or disease stages.
RAB43 genetic variants have been associated with disease risk:
Common Variants: GWAS has identified variants near RAB43 that may influence PD risk. These variants likely affect expression levels rather than protein function.
Rare Variants: Exome sequencing has identified rare missense variants in RAB43 in some PD patients. Functional studies are needed to determine whether these variants are pathogenic.
eQTLs: Expression quantitative trait loci in the RAB43 region influence gene expression. These variants may modify disease risk through altered expression.
Targeting RAB43 and related pathways:
Gene Therapy: Viral vector delivery of wild-type RAB43 could restore proper function. This approach would require careful consideration of expression levels to avoid deleterious effects.
Small Molecules: Modulators of RAB43 GEFs or GAPs could indirectly affect RAB43 activity. This approach may provide more specificity than directly targeting RAB43.
Downstream Targets: Rather than targeting RAB43 itself, modulating downstream pathways (autophagy, lysosomal function) may provide benefit with fewer side effects.
RAB43 interacts with several proteins:
RAB Effectors: RAB43 recruits effector proteins including:
RAB43 is modulated by several signaling pathways:
mTOR Pathway: mTORC1 regulates lysosomal function and autophagy. RAB43 function is downstream of mTOR signaling.
AMP-Activated Protein Kinase (AMPK): Energy sensing via AMPK activates autophagy, which may compensate for RAB43 dysfunction.
Calcium Signaling: Calcium-dependent pathways affect RAB43 membrane association and function.
RAB43 is conserved across species:
Mammals: High conservation with >95% identity between human and mouse Vertebrates: Present in all vertebrate species examined Invertebrates: Drosophila has a RAB43 ortholog with similar function
Important differences between species:
Expression Patterns: Some species-specific expression patterns exist, though RAB43 is consistently enriched in brain.
Isoforms: Alternative splicing generates species-specific variants. The functional significance is under investigation.
Key questions remain about RAB43 in neurodegeneration:
New approaches will advance understanding:
Single-Cell Technologies: Cell-type specific analysis will reveal how RAB43 dysfunction affects different neuronal populations.
Organoids: Brain organoids from PD patients will provide human-relevant models.
Proteomics: Global analysis of RAB43 interactions will identify novel pathways.